Eradication of H. pylori with Pantoprazole, Clarithromycin, and Metronidazole in Duodenal Ulcer Patients: A Head‐to‐Head Comparison Between Two Regimens of Different Duration

@article{Dammann2000EradicationOH,
  title={Eradication of H. pylori with Pantoprazole, Clarithromycin, and Metronidazole in Duodenal Ulcer Patients: A Head‐to‐Head Comparison Between Two Regimens of Different Duration},
  author={H G Dammann and Ulrich Robert F{\"o}lsch and Eckhart G. Hahn and D H von Kleist and Hans Ulrich Kl{\"o}r and Th. Kirchner and Sonja Strobel and Manfred Kist},
  journal={Helicobacter},
  year={2000},
  volume={5}
}
Background. The study was conducted to compare the efficacy and tolerability of two pantoprazole‐based triple therapies of different length in the eradication of H. pylori. 
Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short‐term regimens
  • Frevel, Daake., +4 authors Wack
  • Medicine
  • Alimentary pharmacology & therapeutics
  • 2000
High rates of Helicobacter pylori eradication can be achieved by combining proton pump inhibitors with two antibiotics. However, in the search for an optimal therapy a direct comparison of differentExpand
Eradication of Helicobacter pylori by 7‐Day Triple‐Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double‐Blind, Randomized Studies
TLDR
To compare the short‐term safety and efficacy of two triple‐therapy regimens using pantoprazole with those of two dual‐ther therapy regimens, for Helicobacter pylori eradication in patients with peptic ulcer disease. Expand
Rifabutin‐ and furazolidone‐based Helicobacter pylori eradication therapies after failure of standard first‐ and second‐line eradication attempts in dyspepsia patients
Background : Optimal management approach is not well defined for subjects who fail initial first‐ and second‐line Helicobacter pylori eradication attempts and are dealt on a case‐by‐case basis by theExpand
Recent Use of Proton Pump Inhibitor‐Based Triple Therapies for the Eradication of H. pylori: A Broad Data Review
TLDR
The aim of this study was to systematically review the recent literature on the efficacy of the different regimens of Helicobacter pylori eradication through a broad data review. Expand
Eradication of Helicobacter pylori: current perspectives
TLDR
The current review focuses on the regimens that were used in the past, the present regimens and possibilities for the future, and some other aspects of H. pylori management, such as eradication failures and drug resistance. Expand
Comparison of Three 7-Day Pantoprazole-Based Helicobacter pylori Eradication Regimens in a Mexican Population with High Metronidazole Resistance
TLDR
The 7-day H. pylori eradication regimen with PAC was superior to PCM and PAM, and resistance to metronidazole was present in 68.2% of patients and to clarithromycin in 24.3%. Expand
2‐Week Triple Therapy for Helicobacter pylori Infection is Better Than 1‐Week in Clinical Practice: a Large Prospective Single‐Center Randomized Study
TLDR
The aim of this study was to compare the efficacy of 1‐week versus 2‐week triple therapies in H. pylori‐positive patients. Expand
‘Rescue’ Therapies for the Management of Helicobacter pylori Infection
TLDR
Several studies have obtained relatively good results with triple therapy combining PPI, rifabutin, and amoxicillin, although a reversible myelotoxicity as leukopenia and thrombocytopenia has been described. Expand
Meta-analysis: Duration of First-Line Proton-Pump InhibitorBased Triple Therapy for Helicobacter pylori Eradication
TLDR
An updated meta-analysis of RCTs comparing the efficacy of different durations of triple therapy is performed to verify whether current recommendations reflect the available data and to determine the optimum duration for PPI-based triple therapy for H. pylori eradication. Expand
The impact of Helicobacter pylori resistance on the efficacy of a short course pantoprazole based triple therapy.
TLDR
A short course of pantoprazole-based triple therapy is well tolerated and effective in eradicating Helicobacter pylori and the baseline metronidazole resistance may be a significant limiting factor in treatment success. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 103 REFERENCES
Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection
TLDR
The efficacy and safety of a 1‐week triple therapy regimen of lansoprazole, clarithromycin and metronidazole in an area with a high prevalence of pre‐treatment metronodazole‐resistant strains of Helicobacter pylori is determined. Expand
Two‐week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing
Experience with proton pump inhibitor‐based triple therapy is predominantly with omeprazole‐containing regimens.
Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection
TLDR
The effectiveness and side effect profile of two antibiotics active against Helicobacter pylori, metronidazole and clarithromycin, combined with omeprazole are studied. Expand
Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study
Background.Eradication of Helicobacter pylori provides potential cure in the majority of patients with peptic ulcer disease, and eradication rates of more than 90% have been reported, usingExpand
Rapid eradication of Helicobacter pylori infection
TLDR
A shorter, 7‐day course of treatment for peptic ulcer disease is studied to assess efficacy and tolerability of Helicobacter pylori eradication therapy. Expand
Efficacy and tolerability of a one‐week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer
TLDR
The hypothesis that a triple therapy with pantoprazole, clarithromycin and amoxycillin cures the infection in 80% of duodenal ulcer patients infected with H. pylori is tested. Expand
Failed Treatment of Helicobacter pylori Infection Associated with Resistance to Clarithromycin
TLDR
It is suggested that primary resistance has a significant adverse effect on bacteriological cure rates and acquired resistance develops frequently with failure of treatment following regimens containing clarithromycin. Expand
Randomized comparison of differing periods of twice‐a‐day triple therapy for the eradication of Helicobacter pylori
TLDR
The efficacy, compliance, and tolerability of the twice‐a‐day triple therapy, amoxycillin, omeprazole, and clarithromycin, for Helicobacter pylori is assessed and the effect of treatment duration on these factors is studied. Expand
One Week Triple Therapy for Helicobacter pylori: Does High‐dose Clarithromycin Confer Additional Benef it?
Clarithromycin, a new acid stable macrolide antibiotic with proven efficacy against Helicobacter pylori, has been widely incorporated into eradication regimens but its optimal dosage schedule remainsExpand
Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
Adding Once-Daily Omeprazole 20 mg to Metronidazole/Amoxicillin Treatment for Helicobacter pylori Gastritis: A Randomized, Double-Blind Trial Showing the Importance of Metronidazole Resistance
...
1
2
3
4
5
...